Capacity Expansion and Supply Chain Outlook for U.S. Plasmid DNA Manufacturing
The U.S. plasmid DNA manufacturing market, valued at USD 821.98 million in 2024, is anticipated to expand at a CAGR of 23.3% from 2025 to 2034, with growth increasingly driven by segment-wise performance across scale, end-user applications, and technological platforms. Unlike traditional plasmid production for research, GMP-compliant manufacturing for clinical and commercial use requires...
0 Comments 0 Shares 703 Views 0 Reviews